How Iowa’s new law gets around ACA insurance requirements

Iowa Gov. Kim Reynolds signed legislation into law to allow health plans which don’t comply with Affordable Care Act (ACA) regulations with a new kind of strategy: Defining some insurance plans as something other than health insurance.

Under the new law, “health benefit plans” offered a nonprofit agricultural organization “shall be deemed not to be insurance,” according to the Washington Post. In this case, it opens the door to the Iowa Farm Bureau to offer plans through the state’s largest insurer, Wellmark, to sell plans which can revive elements of pre-ACA insurance design on the individual market, like rejecting customers based on pre-existing conditions.

The result will be less expensive plans available to anyone who is already a member of the Iowa Farm Bureau or pays its $55 annual fee to join. Reynolds said it will restore the healthier individual market that existed in the state before the ACA left it “in collapse.”

Without the individual mandate penalty for failing to buy ACA-compliant insurance, more states could pursue options to open up loopholes for consumers.

“If the ACA’s insurance rules can’t be repealed, then an alternative is to get people the option of escaping them,” said Larry Levitt, a senior vice president at the Kaiser Family Foundation. “Without the penalty, the door is wide open for plans like this.”

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.